Over 20 years of experience in R&D

01 Drug Discovery

Chemistry Research

Biology Research

Early Pharmacokinetics

02 Pharmaceutical Research

Intermediates

Active Pharmaceutical Ingredients

Pharmaceutical preparation

Analytical Method Development and Quality Control

CMC Filings

Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics

Drug Safety Evaluation

DMPK

Bioanalysis

IND Filings

01 One-stop Integrated Services

Liposome Drug Development Service Platform

Drug Discovery Platform

Pharmaceutical Research Platform

Preclinical Research Services

Botanical Drug Preclinical R&D Technology Platform

02 Innovative Drug Services

ADC R&D Service Platform

PROTAC R&D Service Platform

mRNA Vaccine Bioanalysis Platform

Non-clinical Research for Cellular Immunotherapies

Nucleic Acid Drug R&D Platform

Peptide Drug Conjugate (PDC) R&D Service Platform

Antibody R&D Service

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection Platform

Metabolite Identification (MetID) Service Platform

Drug Forming Research Platform

Flow Cytometry Technology Platform

SEND Format Conversion Platform

Flow Sorting Platform

NanoString nCounter Detection Platform

Routes of Drug Administration Platform

04 Drug Efficacy Evaluation for Common Diseases

IO Pharmacodynamic Model Evaluation Platform

Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases

Rodent Cerebrovascular Disease Drug Efficacy Evaluation System

05 Advanced Preparation R&D

Inhalation drug R&D platform

Ophthalmic drug R&D platform

Skin Topical Preparation R&D Platform

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service

GLP-1 New Drug R&D Service

KRAS-targeted Drugs R&D Service

2024-07-22Medicilon Events

The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together

On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.

Learn more

2024-07-22Medicilon Events

5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"

Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.

Medicilon 688202

RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER

Intellectual Property Protection

U.S.

Address: 470 Wildwood Ave, Woburn, MA 01801 (America)

Tel: +1(626)986-9880

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Shanghai Public Network Security File No. 31011502018888 | Website Map

Drug Discovery

FAQs

HomeservicesDrug DiscoveryBiology ResearchStructural BiologyX-ray-based Crystal Structural Biology

X-ray-based Crystal Structural Biology

The measurement of the complete three-dimensional structure of a protein and its complex assembly is the scientific basis for studying the relationship between molecular structure and function in life activities, as well as for revealing the physical and chemical nature of life phenomena. X-ray diffraction of protein and its complex crystals is one of the main methods used to study the three-dimensional fine structure of biological macromolecules.

Combining with other disciplines, and especially driven by fields like structural genomics, protein crystallography extends from analyzing the simple three-dimensional structure of proteins to studying the structures of various biological macromolecules and complexes, focusing on the relationship between structure and function. In pharmaceutical R&D, protein crystallographic structure is widely and significantly used in structure-based novel drug design.

Services we offer

High-throughput-based selection of protein crystalsDiffraction data collection in protein synchrotron radiationProtein-compound co-crystallizationAnalysis of protein crystal structure

Items and Steps

Step	Content	Duration	Remark
1	High-throughput-based selection of protein crystals	4-8 weeks	Commercial selection kit, Mosquito selection
2	Diffraction data collection in protein synchrotron radiation	4-8 weeks	Diffraction data collection in synchrotron radiation for Shanghai
3	A. Protein-compound co-crystallization; B. Fragment selection	4-8 weeks	Compound-binding constant obtained via ITC and Biacore testing recommended
4	Analysis of protein crystal	Determined based on specific project	Phase analysis of molecular replacement and heavy metal replacement

Remarks

You can choose any of the above experiments, or a combination of related experiments, according to your requirements.

Case study-KRAS related assays

KRAS-G12D crystallization
Screening of KRAS^G12D
$Synchrotron X-ray diffraction data of the co-crystallization.webp$
Synchrotron X-ray diffraction data of KRAS^G12D
Compare the Structure of KRAS^G12D with 7RPZ, the green is PDB ID 7RPZ and the pink is the data from Medicilon. The data are very correlated.
KRAS-G12D-MRTX1133 co-crystallization
Screening of the co-crystallization
$Synchrotron X-ray diffraction data of KRASG12D.webp$
Synchrotron X-ray diffraction data of the co-crystallization
Compare the Structure of KRAS^G12D co-crystallization with MRTX1133(7RPZ, PDB), the green strucuture is PDB ID 7RPZ and the cyan is data from Medicilon. The data are very correlated.
Structure of KRAS^GI2D co-crystallized with MRTX1133 with GDP-bound